Ashland Inc., a Delaware-based chemical company, is currently weighing potential bids for its business. This follows engagement from private equity firms and interested investors, according to sources. These sources are with knowledge of the situation. The move follows a July agreement with activist investor Ancora Holdings. This agreement helped set the groundwork for the exploration of a sale.
Who’s in the running?
Leading the list of potential buyers are major private equity players. These include Advent International, Apollo Global Management, and the Carlyle Group. All of these have reportedly initiated discussions with Ashland. Standard Industries has also expressed interest in the company. This is through its investment arm, Standard Investments. The company produces additives and specialty ingredients. These are for use in pharmaceuticals, construction materials, and personal care items.
Ashland is handling the evaluation of both strategic and financial acquisition proposals with the assistance of its financial advisors Citigroup and Lazard. However, the process is still in early stages and does not guarantee a transaction. So far, the company has remained silent on the matter, and neither Ashland nor Standard Industries have responded to requests for clarification.
The activist push
The current developments follow a recent agreement between Ashland and Ancora Holdings. This is an activist investment group. The July settlement led to the addition of two new members to the company's board. It also led to the creation of a capital allocation committee. This committee will remain in place through the 2028 annual shareholder meeting. At a June industry conference, Ancora Alternatives made an estimate. This is the investing division of Ancora. It estimated that a sale could potentially increase Ashland’s stock value by at least 30%.
Cruiser Capital Advisors, another institutional shareholder, supported the newly added board members—Allen Spizzo and Peter Thomas—and the resulting settlement. This came just two months after Ancora revealed it had taken a position in Ashland and publicly urged the company to consider selling itself.
Ashland’s stock on the rise
Shares of Ashland climbed sharply this week. They rose 5.5% to close at $76.45 Friday. The stock’s performance reflects growing interest in the specialty chemical sector. This sector has seen a surge in M&A activity. Companies seek to position themselves in key growth areas.
Recent industry transactions underscore the ongoing demand. Honeywell International’s spin-off, Solstice Advanced Materials, signed a $14.5 billion deal in July to acquire Element Solutions, a producer of materials used in semiconductor packaging. This activity highlights the rising importance of chemical companies in sectors such as energy, power, and artificial intelligence.